The DOI matches its Crossref record; 272 of the 272 references it cites were found in a registry or an index.
Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance
Abstract
Self-assembled nanostructures of amphiphilic and double hydrophilic block copolymers have been increasingly utilized as potent polymeric nanocarriers of therapeutic drugs, genes, bioactive molecules, and imaging/contrast agents due to improved water solubility, bioavailability, and extended blood circulation duration. Though passive and active targeted drug delivery strategies have long been proposed to promote desirable drug accumulation specifically at the disease sites, the introduction of stimuli-responsiveness into self-assembled block copolymer nanocarriers can additionally lead to controlled/triggered release of therapeutic/imaging agents into target pathological tissues and cells, with concomitant advantages of enhanced delivery efficiency and therapeutic efficacy. Appropriately designed stimuli-responsive block copolymer assemblies can exhibit chemical structure transformation, microstructural rearrangement and inversion, or even disassembly into unimers or smaller ones under external stimuli such as pH, temperature, ion strength, redox potential, light, electric, and magnetic fields, and specific bioactive molecules and metabolites. Compared to normal tissues, pathological sites such as tumor tissues typically exhibit vascular abnormalities, weak acidity (~pH 6.8), abnormal temperatures, over-expressed proteins and enzymes, hypoxia, high levels of metabolites and reactive small molecule species, etc. Moreover, upon cellular uptake, drug-loaded polymeric nanocarriers will be subjected to intracellular pH gradients (pH 5.9-6.2 in early endosomes and pH 5.0-5.5 in late endosomes and lysosomes) and redox and H2O2 gradients within different cell organelles and the cytosol. Thus, block copolymer nanocarriers responsive to the above described bio-relevant stimuli or biochemical signals characteristic of pathologic tissues and cells will provide an alternative type of "active targeting" strategy, which can be utilized to further boost therapeutic efficacy and imaging sensitivity via disease site-specific delivery and controlled release. A variety of extracellular or intracellular stimuli innate to disease sites, such as mildly acidic pH, temperature, enzymes (matrix metalloproteinase, β-glucuronidase, and phosphatase), oxidative/reductive microenvironments, and abnormal levels of bioactive molecules or metabolites, have been utilized for this purpose. In this review, we summarize recent advances in stimuli-responsive block copolymer assemblies which are responsive to tumor and intracellular microenvironments and their applications in anticancer drug delivery and enhanced imaging sensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Poly(N-isopropylacrylamide): experiment, theory and application
Schild, H. G. (1992) · Progress in Polymer Science · doi:10.1016/0079-6700(92)90023-r · Cited by 5,147
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Glutathione Metabolism and Its Implications for Health
Wu, G., Lupton, J. R., Turner, N. D., Fang, Y.-Z., & Yang, S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.3.489 · Cited by 3,842
Self-assembly of block copolymers
Mai, Y., & Eisenberg, A. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35115c · Cited by 3,610
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Cited by
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Supramolecular Amphiphiles Based on Host–Guest Molecular Recognition Motifs
Yu, G., Jie, K., & Huang, F. (2015) · Chemical Reviews · doi:10.1021/cr5005315 · Cited by 1,025
Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
Mi, P. (2020) · Theranostics · doi:10.7150/thno.38069 · Cited by 830
Cancer nanomedicine: from targeted delivery to combination therapy
Xu, X., Ho, W., Zhang, X., Bertrand, N., & Farokhzad, O. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.001 · Cited by 693
Feng, T., Ai, X., An, G., Yang, P., & Zhao, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b00043 · Cited by 650
Hu, X., Hu, J., Tian, J., Ge, Z., Zhang, G., Luo, K., & Liu, S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja409686x · Cited by 605
Self-citationCancer Treatment through Nanoparticle-Facilitated Fenton Reaction
Ranji-Burachaloo, H., Gurr, P. A., Dunstan, D. E., & Qiao, G. G. (2018) · ACS Nano · doi:10.1021/acsnano.8b07635 · Cited by 559
Wu, X., Sun, X., Guo, Z., Tang, J., Shen, Y., James, T. D., Tian, H., & Zhu, W. (2014) · Journal of the American Chemical Society · doi:10.1021/ja412380j · Cited by 539
Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems
Wen, J., Yang, K., Liu, F., Li, H., Xu, Y., & Sun, S. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00219j · Cited by 477
Nanoparticles in Drug Delivery: From History to Therapeutic Applications
Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468
Advances in redox-responsive drug delivery systems of tumor microenvironment
Guo, X., Cheng, Y., Zhao, X., Luo, Y., Chen, J., & Yuan, W.-E. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0398-2 · Cited by 459
The acidic tumor microenvironment: a target for smart cancer nano-theranostics
Feng, L., Dong, Z., Tao, D., Zhang, Y., & Liu, Z. (2018) · National Science Review · doi:10.1093/nsr/nwx062 · Cited by 426
Tian, H., Zhang, T., Qin, S., Huang, Z., Zhou, L., Shi, J., Nice, E. C., Xie, N., Huang, C., & Shen, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01320-5 · Cited by 426
Supramolecular cancer nanotheranostics
Zhou, J., Rao, L., Yu, G., Cook, T. R., Chen, X., & Huang, F. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00011f · Cited by 411
Tritschler, U., Pearce, S., Gwyther, J., Whittell, G. R., & Manners, I. (2017) · Macromolecules · doi:10.1021/acs.macromol.6b02767 · Cited by 375
Prodrug-based nanoparticulate drug delivery strategies for cancer therapy
Luo, C., Sun, J., Sun, B., & He, Z. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.008 · Cited by 352
The advanced role of carbon quantum dots in nanomedical applications
Devi, P., Saini, S., & Kim, K.-H. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.02.059 · Cited by 349
Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy
Zamora, A., Vigueras, G., Rodríguez, V., Santana, M. D., & Ruiz, J. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.01.010 · Cited by 345
Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery
Sun, C.-Y., Shen, S., Xu, C.-F., Li, H.-J., Liu, Y., Cao, Z.-T., Yang, X.-Z., Xia, J.-X., & Wang, J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09602 · Cited by 343
Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment
Chen, B., Dai, W., He, B., Zhang, H., Wang, X., Wang, Y., & Zhang, Q. (2017) · Theranostics · doi:10.7150/thno.16684 · Cited by 342
Hu, X., Liu, G., Li, Y., Wang, X., & Liu, S. (2015) · Journal of the American Chemical Society · doi:10.1021/ja5105848 · Cited by 325
Self-citationChemiluminescence-Guided Cancer Therapy Using a Chemiexcited Photosensitizer
Mao, D., Wu, W., Ji, S., Chen, C., Hu, F., Kong, D., Ding, D., & Liu, B. (2017) · Chem · doi:10.1016/j.chempr.2017.10.002 · Cited by 317
Feng, C., Wang, Y., Xu, J., Zheng, Y., Zhou, W., Wang, Y., & Luo, C. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121582 · Cited by 317
Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy
Zhai, Y., Su, J., Ran, W., Zhang, P., Yin, Q., Zhang, Z., Yu, H., & Li, Y. (2017) · Theranostics · doi:10.7150/thno.20118 · Cited by 312
Organic Dye Based Nanoparticles for Cancer Phototheranostics
Cai, Y., Si, W., Huang, W., Chen, P., Shao, J., & Dong, X. (2018) · Small · doi:10.1002/smll.201704247 · Cited by 306
Wang, X., Hu, J., Liu, G., Tian, J., Wang, H., Gong, M., & Liu, S. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b10127 · Cited by 297
Self-citationChi, X., Ji, X., Xia, D., & Huang, F. (2015) · Journal of the American Chemical Society · doi:10.1021/ja512978n · Cited by 296
Wang, S., Wang, Z., Yu, G., Zhou, Z., Jacobson, O., Liu, Y., Ma, Y., Zhang, F., Chen, Z., & Chen, X. (2019) · Advanced Science · doi:10.1002/advs.201801986 · Cited by 292
Han, S.-S., Li, Z.-Y., Zhu, J.-Y., Han, K., Zeng, Z.-Y., Hong, W., Li, W.-X., Jia, H.-Z., Liu, Y., Zhuo, R.-X., et al. (2015) · Small · doi:10.1002/smll.201402865 · Cited by 269
Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors
Miao, L., Lin, C. M., & Huang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.017 · Cited by 264
MMP-2 responsive polymeric micelles for cancer-targeted intracellular drug delivery
Chen, W.-H., Luo, G.-F., Lei, Q., Jia, H.-Z., Hong, S., Wang, Q.-R., Zhuo, R.-X., & Zhang, X.-Z. (2015) · Chemical Communications · doi:10.1039/c4cc07563c · Cited by 115
Fu, L., Sun, C., & Yan, L. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am508291k · Cited by 78
Jin, Y., Liang, X., An, Y., & Dai, Z. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00603 · Cited by 72
Li, H., Li, J., Ke, W., & Ge, Z. (2015) · Macromolecular Rapid Communications · doi:10.1002/marc.201500337 · Cited by 47
Self-citationAmphiphilic block copolymers–based micelles for drug delivery
Imran, M., Shah, M. R., & Shafiullah (2018) · Design and Development of New Nanocarriers · doi:10.1016/b978-0-12-813627-0.00010-7 · Cited by 35
Cheng, C.-C., Huang, J.-J., Lee, A.-W., Huang, S.-Y., Huang, C.-Y., & Lai, J.-Y. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00146 · Cited by 25
Chen, W., Su, L., Zhang, P., Li, C., Zhang, D., Wu, W., & Jiang, X. (2017) · Polymer Chemistry · doi:10.1039/c7py01389b · Cited by 21
Metadata
- Authors
- Ge, Z., & Liu, S.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 42
- Issue
- 17
- Pages
- 7289
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W1982461928
- Cited by
- 914
- References
- 272
- FWCI
- 6.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.